F O C U S a long-term cooperation agreement with Wison Engineering Ltd and a subsidiary of Foster Wheeler’s Global Engineering and Construction Group to equip coal based methanation plants based on VESTA technology in China, the world’s largest SNG market, with catalysts of Clariant. Original Source: Clariant International Ltd, Rothaustrasse 61, CH-4132 Muttenz 1, Switzerland, website: http://www.clariant.com) (21 Oct 2013) © Clariant 2013
Dow divests global polypropylene licensing & catalysts business Dow Chemical Co has signed a definitive agreement under which Dow’s global Polypropylene Licensing & Catalysts business will be divested to WR Grace & Co for a sale price of $500 M. Dow expects to report a gain on this divestment and net proceeds will be directed toward the Company’s main priorities of remunerating shareholders, debt reduction and funding growth. The transaction is expected to close by the end of 2013, pending regulatory clearance. Dow had previously announced its intent to divest this business on 14 Mar 2013, as part of the Company’s ongoing commitment to proactive portfolio management and plan to divest nearly $1.5 bn in assets by mid to late 2014. The divestiture includes Dow’s polypropylene catalysts manufacturing facility at Norco, LA and customer contracts, licenses, intellectual property and inventory. Approximately 90 employees globally are expected to transition employment status to WR Grace & Co as part of the transaction. Under terms of the purchase agreement, WR Grace & Co will honour customer, licensing and supplier contracts and related agreements. Both companies are committed to working together for a seamless transition for all stakeholders. Original Source: Dow Chemical Co, 2030, Dow Centre, Midland, MI 48642, USA, tel: +1 989 636 1000, fax: +1 989 636 3518, website: http://www.dow.com (11 Oct 2013) © The Dow Chemical Company 2013. Original Source: WR Grace & Co, website: http://www.grace.com (11 Oct 2013) © WR Grace & Co - Conn 2013. Original Source: Chemie Aktuell, 17 Oct 2013, (Website: http://www.maerkte-weltweit.de) (in German) © MBM Martin Brueckner Medien GmbH 2013. Original Source: Chimie Pharma Hebdo, 21 Oct 2013, (651), (Website: http://www.industrie.com/chimie) (in French) © ETAI Information 2013
DECEMBER 2013
O N
C ATA LY S T S
Enerkem partners Canadian Government in waste-to-fuels project Enerkem, a Canada-based waste-tobiofuels and renewable chemicals company, has partnered with the Canadian government on a research project aiming to develop new catalytic processes for converting waste into so-called drop-in biofuels. The government will spend $1.1. M on the project through Natural Resources Canada. Enerkem has developed technology for the production of chemical-grade syngas as a key intermediate for making chemicals and fuels. Original Source: Chemistry and Industry (London), Jul 2013, 77 (7), 12 (Website: http://www.soci.org/) © Society of Chemical Industry 2013
Gazprom Neft, UOP, and ExxonMobil Research and Engineering Co finalize technology licensing agreement UOP LLC (UOP), a Honeywell company, and ExxonMobil Research and Engineering Co (EMRE) have finalized a technology licensing agreement with a subsidiary of Gazprom Neft under Honeywell’s UOP and EMRE’s joint marketing alliance. The new technology will enable Gazprom to improve its production of refined distillates at its subsidiary, the Moscow Oil Refinery Plant. The refiner will combine UOP Distillate Unionfining hydroprocessing solutions with EMRE’s distillate dewaxing technology to produce lowsulfur diesel. Original Source: Honeywell, 2013. Found on PR Newswire, 17 Oct 2013, (Website: http://www.prnewswire.com)
INVISTA and Ingenza collaborate to develop new bio-derived processes for industrial chemicals US-based INVISTA and Ingenza announce a collaboration for the development of new technologies to enable bio-derived processes for the production of industrial chemicals. The collaboration will leverage INVISTA’s capabilities in biotechnology and catalysis, and knowledge of the chemicals industry, and Ingenza’s synthetic biology and industrial biotechnology capabilities
for the development of new, bioderived routes to industrial chemicals. Original Source: INVISTA, 2013. Found on SpecialChem Cosmetics and Personal Care Innovation and Solutions, 4 Oct 2013, (Website: http://www.specialchem4cosmetics.com)
LyondellBasell opens technology centre in Houston. LyondellBasell has officially opened a new technology centre at Houston, TX. This will focus on developing processes and catalysts for LyondellBasell’s chemical intermediates and derivatives activity. The centre will have a workforce of around 80. Original Source: LyondellBasell Industries, 2013. Found on PR Newswire, 30 Sep 2013, (Website: http://www.prnewswire.com). Original Source: Chimie Pharma Hebdo, 7 Oct 2013, (649), (Website: http://www.industrie.com/chimie) (in French) © ETAI Information 2013. Original Source: Chemical and Engineering News, 7 Oct 2013, 91 (40), 24 (Website: http://www.cen-online.org) © American Chemical Society 2013
Novozymes launches new detergent enzyme range On 9 Oct 2013, Novozymes announced the launch of a new product range of highly stable and robust enzymes for both liquid and powder detergents that will help detergent producers to deliver consistent wash performance to consumers every time. The improved stability and wash performance comes from the product range called Evity, developed by Novozymes to help detergent producers. “The new Evity powder enzyme range comes with a new technology that safeguards the enzyme - regardless of the harsh ingredients and challenges a detergent faces on its journey from factory to washing machine,” says Cynthia Bryant, Director of Novozymes Household Care Marketing. “It enables the producers of detergents to ensure that consumers experience a consistently high wash performance every time.” Novozymes’ new Evity product range is developed especially to help detergents to stay effective for longer. Original Source: Novozymes A/S, Krogshojvej 36, 2880 Bagsvaerd, Denmark, tel: +45 4446 0000, fax: +45 4446 9999, e-mail:
[email protected], website: http://www.novozymes.com (9 Oct 2013) © Novozymes A/S 2013
3